Drug-maker Hetero has entered into a licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of ‘Remdesivir’ for the tr
from Business Line - Companies https://ift.tt/35WpUwo
from Business Line - Companies https://ift.tt/35WpUwo
Comments
Post a Comment